<DOC>
	<DOCNO>NCT00150800</DOCNO>
	<brief_summary>This trial , evaluate long-term safety tolerability brivaracetam provide subject suffer epilepsy , may benefit brivaracetam adjunctive treatment , opportunity receive open label brivaracetam treatment .</brief_summary>
	<brief_title>This Trial , Evaluating Long-term Safety Tolerability Brivaracetam Will Provide Subjects Suffering From Epilepsy , Who May Have Benefited From Brivaracetam Adjunctive Treatment , Opportunity Receive Open Label Brivaracetam Treatment</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Male/ female subject 16 year . Subjects 18 year may include legally permit ethically accepted Subjects epilepsy participate previous brivaracetam trial allow access present study Subjects investigator believe reasonable benefit long term administration brivaracetam may expect Female subject without childbearing potential . Female subject child bear potential eligible use medically accept contraceptive method duration study Subject/ legally acceptable representative consider reliable capable adhere protocol , visit schedule medication intake accord judgment Investigator Severe medical , neurological psychiatric disorder laboratory value may impact safety subject Poor compliance visit schedule medication intake previous brivaracetam study Pregnant lactate woman Participation clinical study another investigational drug device study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>open label</keyword>
</DOC>